Suppressive effects of standard-dose rosuvastatin therapy on the progression of coronary atherosclerosis in Japanese patients: the APOLLO study.


AIM We used quantitative coronary angiography (QCA) to investigate whether coronary plaque progression can be inhibited by controlling lipids with rosuvastatin at Japanese standard doses following elective percutaneous coronary intervention (PCI). METHODS A total of 143 patients who underwent elective PCI were randomized to either the rosuvastatin (5 or 2… (More)


  • Presentations referencing similar topics